The most widely accepted biological method for estimation of follicle stimulating hormone (FSH)was that of Steelman-Pohley(Steelman and Pohley, 1953) , and the most sensitive biological method specific for luteinizing hormone(LH)was devised by A. F. Parlow in 1958, utilizing ovarian ascorbic acid depletion (Mindlin and Butler, 1938) . Their uses in specific estimation of FSH and LH have led to basic analyses concerning with the physiological role of FSH and LH in hypothalamic pituitary system, and clarifications of FSH and LH excretion in urine in normal menstrual cycle (Fukushima et al., 1964 
Materials and Methods

Recipient
The intact immature female mice of ICR-JCL strain, which had been imported from the Charles River Breeding Laboratory in U.S.A., were obtained from the Japan Clea Laboratory at 18 days of age. They were bred in the airconditioned room having a constant humidity and temperature with lightening schedules from 6.00a.m. to 8.00p.m. of HCG In 6 doses as 0.200, 0.150, 0.100, 0.075, 0.050, and 0.025iu of HCG, uterine weight responses to 0, 2.0, 10.0, and 50.0 ug of NIH-FSH-S5 were observed and these dose response curves were statistically treated through variance analysis, calculating regression lines, F-ratio of linearity(VL) and quadraticity(VQ), and lambda as shown in Table 1 Effect of Prolactin: i) Uterine weight responses to 25, 50, 100, 200, and 400 mu of NIH-P-S7 with 0.15iu of HCG were statistically treated, indicating the MPCD for P to be less than 25 mu equiv. of NIH-P-S7. ii) The MPCD for P was remained uncertain to be less than 12.5 mu equiv. of NIH-P-57. iii) Uterine weight responses to above mentioned concentrations of Prolactin with 0.10iu of HCG led the undecided MPCD to be less than 12.5 mu equiv. of NIH-P-S7. iv) The above mentioned doses of NIH-P-S7 with 0.075iu of HCG failed to give significant differences from the control uterine weight response, determining the MPCD for P to be 400 mu equiv. of NIH-P-S7, as shown in Table 8 . Effect of ACTH: 0.10 and 0.075iu of HCG were tested for uterine weight responses to Figure 4 . Results revealed that the MPCD for ACTH with 0.10iu of HCG was remained to be less than 50 mu equiv. of Armour-ACTH, however, the MPCD for ACTH with 0.075iu of HCG was determined to be 200 mu equiv. of Armour-ACTH. Effect of TSH: 0.10iu and 0.075iu of HCG mƒÊg/ml after insulin administration (Vinik et al., 1970) , and 16B51mƒÊg/ml in acromegaly (Shizume, 1969) . Through these results, the measurement of FSH in human plasma can be performed without non-specific interference of GH in the plasma, as far as less than 2ml of the plasma is utilized for the assay. Recently, GH concentration in human anterior pituitary gland was estimated as 7-8U/gland equiv. of NIH-GH-HS705A (1.45U/mg) (Oliner et al., 1968) , so it is concluded that FSH assay in human pituitary may be difficult without interference of GH. (Amenomori et al., 1970) , indicating the level of plasma prolactin of female rats far below the level of the MPCD for prolactin in this method with 0.075iu of HCG. There were a few studies about human prolactin concentration in plasma as non-detectable level in normalcyclic period (Fujii, 1969 ), 1.2-2.4 iu/ml in pregnancy, 8B32 iu/ml after delivery (Otsuka, 1968) , or 0.001-0.2iu/ml in normal cyclic woman (Simkin and Goodart, 1960; Bahn and Bates, 1956 ). Daily urinary excretion of prolactin was demonstrated as 16 iu in secretory phase, 32 iu in pregnancy, or 64 iu on 4th day of puerperium (Shimizu, 1958 (Sydnor and Sayer, 1953) . ACTH concentration in plasma of rat was reported to be remarkably low, in spite of the urgent elevation of ACTH in plasma by various stressful stimulations, and ACTH level in plasma after adrenectomy was considered to correspond to the maximum range in physiological condition. Therefore, FSH measurement in rat plasma can be performed specifically in this method with 0.075 iu of HCG. Human urinary excretion of ACTH was reported as 1.0-3.1iu/l in male and 1.0-8.2iu/l in female (Rubin et al., 1954) , undetectable level (Locke et al., 1949) , or 0.25 mu/day (Fujita, 1957) . In measurement of urinary FSH excretion, the contamination of ACTH was confined within the level of the MPCD for ACTH assaying 20min urine in this method. ACTH concentrations in human plasma were reported as 0.1-0.59mu/dl (Ney et al., 1963) , 0.71mu/dl (Vance et al., 1962) , and 0.5mu/dl (Demura et al., 1966) in normal condition, or 0.9-93.8mu/dl in Addison's disease, 1.4-74.0mu/dl in , pituitary tumor producing ACTH, and 0.21-9.8mu/dl in congenital adrenocortical hyperplasia (Imura, 1965) . In our routine assay of plasma FSH utilizing less than 2ml of plasma, ACTH contamination was far below the level of the MPCD for ACTH. ACTH concentration in human pituitary gland was demonstrated as 10.4U/gland (Oliner et al., 1968) level of the MPCD for TSH, excluding completely the non-specific response of TSH. As to human urinary excretion of TSH, it is generally accepted that TSH excretion in urine might be considerably low through inactivation by various organs (Levey and Solomon, 1956; and has no interference on estimation of FSH in this method. TSH concentrations in human plasma were demonstrated as 0.2mu/ml (McKeuzie, 1958) , 0.01-0.012mu/ ml (Purves and Adams, 1960) , or 0.002mu/ml (Bakke et al., 1960) in bioassay and less than 0.01mu/ml in radioimmunoassay (Odell et al., 1965) , which increase to 1.0-4.5mu/ml in hypothyroidism and decrease to less than 0.0045mu/ml in hyperthyroidism (Odell et al., 1967) . 
